Why, who and how should perform liver biopsy in chronic liver diseases
Authors:
- Ioan SporeaISIoan Sporea
- Alina PopescuAPAlina Popescu
- Roxana SirliRoxana Sirli
Open Access
- 1 January 2008
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 14 (21) , 3396-3402
Abstract
Why, who and how should perform liver biopsy in chronic liver diseasesKeywords
This publication has 54 references indexed in Scilit:
- Importance of Specimen Size in Accurate Needle Liver Biopsy Evaluation of Patients With Chronic Hepatitis CClinical Gastroenterology and Hepatology, 2005
- Short Recovery Time After Percutaneous Liver Biopsy: Should We Change Our Current Practices?Clinical Gastroenterology and Hepatology, 2005
- Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis CHepatology, 2004
- 729 Diagnostic value of biochemical markers (fibrotest) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease (NAFLD)Hepatology, 2003
- Role of liver biopsy in management of chronic hepatitis C: A systematic reviewHepatology, 2002
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- Cost-effectiveness of ultrasound-guided liver biopsyHepatology, 1998
- Is day case liver biopsy underutilised?Gut, 1995
- Complications associated with percutaneous needle biopsy of the liver when one, two or three specimens are takenPostgraduate Medical Journal, 1992
- Complications following percutaneous liver biopsyJournal of Hepatology, 1986